Calamos Advisors »

Halozyme Therapeutics shares owned by Calamos Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.0M 4.6M 0.86
2023-09-30 $3.9M 4.6M 0.85
2023-06-30 $5.9M 7.1M 0.83
2023-03-31 $6.1M 7.2M 0.85
2022-12-31 $5.8M 5.9M 0.97
2022-09-30 $20M 24M 0.85
2022-06-30 $39M 44M 0.88
2022-03-31 $38M 44M 0.88